Substance / Medication

Foscarnet

Overview

Active Ingredient
foscarnet
RxNorm CUI
33562

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

5 trials linked to this intervention

5
Total Trials
0
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Antiviral therapeutic efficacy of foscarnet in hepatitis B virus infection.
Han Yan-Xing, Xue Rong, Zhao Wei et al. · Antiviral Res · 2005
PMID: 16280177RCT
Safety of pre-engraftment prophylactic foscarnet administration after allogeneic stem cell transplantation.
Ishiyama K, Katagiri T, Ohata K et al. · Transpl Infect Dis · 2012
PMID: 21794043Trial
Preemptive therapy of human herpesvirus-6 encephalitis with foscarnet sodium for high-risk patients after hematopoietic SCT.
Ishiyama K, Katagiri T, Hoshino T et al. · Bone Marrow Transplant · 2011
PMID: 20838386Trial
Foscarnet salvage therapy for patients with late-stage HIV disease and multiple drug resistance.
Canestri Ana, Ghosn Jade, Wirden Marc et al. · Antivir Ther · 2006
PMID: 16964823Trial
Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis.
Weinberg Adriana, Jabs Douglas A, Chou Sunwen et al. · J Infect Dis · 2003
PMID: 12599051Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Foscarnet (substance)
SNOMED CT
372902006
UMLS CUI
C0070895
RxNorm CUI
33562

Clinical Data

This intervention maps to 2 entities in the Ltrl knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
5
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.